BPC-157 has shown significant potential in enhancing the healing of skin wounds, muscle injuries, and tendon damage in preclinical models
doi: 10.3390/molecules25030556 138
10.3389/fmicb.2016.00444
Biohacker Protocol (experimental) Dose: 0.05 0.1 mg (= 24 clicks) Duration: 4 6 weeks Frequency: Daily microdose before rest cycle Cycle Interval: 1 2 weeks off before repeating Goal / Description: Low-dose continuous exploration of sleep quality and recovery markers
In general, Australia researchers think that BPC-157 promotes healing, lowers inflammation, and supports general tissue health and well-being by combining angiogenic, anti-inflammatory, and antioxidant mechanisms
They reported that there were marked differences in the microbiota composition due to the specific antimicrobial, as well as notable differences in relative abundance of resistome genes by database search of metagenomes against the Antibiotic Resistance Genes Database 4,21